Table 1.
Ion channels and the control of blood pressure
Ion channel | Location where channel influences blood pressure | Effect of increased channel activity on blood pressure | Drugs which open ion channel | Effect of decreased channel activity on blood pressure | Drugs which block ion channel |
---|---|---|---|---|---|
Epithelial sodium channel | Renal collecting duct | Increases blood pressure (Liddle's syndrome, T594M mutation?) | Decreases blood pressure (Pseudohypoaldosteronism) | Amiloride, triamterene | |
Renal outer medullary potassium channel (ROM K) | Kidney (loop of Henle) | Low/normal blood pressure (Bartter's syndrome) | Glibenclamide | ||
Cystic fibrosis transmembrane regulator (CFTR) | ?Renal tubules ??Sweat ducts | Some evidence for low blood pressure (Cystic fibrosis) | |||
Cation channel | Vascular endothelial cells | ?Lowers blood pressure | LP-805 | ||
Voltage-gated calcium channel | Vascular smooth muscle cells | Lowers blood pressure | Nifedipine Amlodipine Diltiazem Verapamil | ||
ATP-sensitive potassium channel | Vascular smooth muscle cells | Lowers blood pressure | Nicorandil Cromokalim Pinacidil | Increases blood pressure | Glibenclamide |